Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.
Eli Lilly & Co. ( LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026.
Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...
A new trend gaining popularity among people ... prescribed for managing type 2 diabetes and aiding weight loss, experts ...
Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...
The U.S. FDA has released a new draft guidance for drugmakers ... adding no CV signals have been observed with that drug. Two of the most prescribed drugs for weight loss are GLP-1s: Novo ...